A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes

Novo Nordisk

Status: Completed

Conditions: Diabetes Mellitus, Type 1; Diabetes; Diabetes Mellitus, Type 2

Treatments: Other: No treatment given

Study type: Observational

Funder types: Industry

Identifiers

NCT02306681

U1111-1161-9157 (Other Identifier)

INS-4177

Details and patient eligibility

About

This study is conducted globally. The aim of this study is to describe the proportion of patients with hypoglycaemic episodes and estimate the incidence of various types of hypoglycaemia in the retrospective and prospective periods.

Enrollment: 7,315 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Informed consent obtained before any trial-related activities
• Patient with T1DM or T2DM treated with insulin for more than 12 months
• Male or female patient at least 18 years of age at the time of inclusion in the study

Exclusion criteria

• Previous participation in this study
• Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
• Illiterate patients and patients otherwise unable to sign the Informed Consent or complete a written survey
• Non-ambulatory patients
• Simultaneous participation in any other clinical study with an investigational product

Trial design

7,315 participants in 1 patient group

SAQ-Self-Assessment Questionnaire

Treatment:

Other: No treatment given